Summary
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The report forecast global Paclitaxel market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Paclitaxel industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Paclitaxel by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Paclitaxel market for 2016-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Paclitaxel according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Paclitaxel company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI(Teva)
Fresenius-kabi
Southpharma
Haiyao
Huiang biopharma
Yunnan Hande
Hainan Yew Pharm
Market by Type
Natural Paclitaxel
Semi-synthetic Paclitaxel
Market by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Summary:
Get latest Market Research Reports on Paclitaxel. Industry analysis & Market Report on Paclitaxel is a syndicated market report, published as (COVID Version) Global Paclitaxel Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use. It is complete Research Study and Industry Analysis of Paclitaxel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.